128 related articles for article (PubMed ID: 8342112)
1. The RBE of negative pions in the treatment of tumors with different volumes.
Jüling-Pohlit L; Blattmann H; Pedroni E; Pohlit W
Strahlenther Onkol; 1993 Jul; 169(7):394-404. PubMed ID: 8342112
[TBL] [Abstract][Full Text] [Related]
2. Repair inhibition in tumours irradiated with fast protons and negative pions.
Jüling-Pohlit L; Pohlit W; Blattmann H
Strahlenther Onkol; 1990 Jan; 166(1):6-9. PubMed ID: 2154049
[TBL] [Abstract][Full Text] [Related]
3. Variations of pion RBE in a volume with an asymmetric beam configuration.
Rao KR; Blattmann H; Fritz-Niggli H
Strahlenther Onkol; 1987 Nov; 163(11):739-41. PubMed ID: 3686337
[TBL] [Abstract][Full Text] [Related]
4. Effect of different stopping volumes of clinical pion beams at TRIUMF on the mouse small intestine.
Saito T; Chaplin DJ; Lam GK; Skarsgard LD
Radiat Res; 1989 Jan; 117(1):8-20. PubMed ID: 2492379
[TBL] [Abstract][Full Text] [Related]
5. The RBE of euoxic and hypoxic Ehrlich ascites tumour cells irradiated with negative pions in vitro and in vivo.
Jüling-Pohlit L; Latz D; Pohlit W; Thonke A
Radiother Oncol; 1990 Sep; 19(1):57-72. PubMed ID: 2122496
[TBL] [Abstract][Full Text] [Related]
6. Pions for radiotherapy at TRIUMF.
Skarsgard LD; Henkelman RM; Eaves CJ
J Can Assoc Radiol; 1980 Mar; 31(1):3-12. PubMed ID: 7364844
[TBL] [Abstract][Full Text] [Related]
7. Proportional counter dosimetry and microdosimetry for radiotherapy with multiple pion beams.
Schuhmacher H; Menzel HG; Blattmann H; Muth H
Radiat Res; 1985 Jan; 101(1):177-96. PubMed ID: 3918330
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological effectiveness (RBE) of megavoltage X-ray and electron beams in radiotherapy.
Amols HI; Lagueux B; Cagna D
Radiat Res; 1986 Jan; 105(1):58-67. PubMed ID: 3080801
[TBL] [Abstract][Full Text] [Related]
9. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
[TBL] [Abstract][Full Text] [Related]
10. Review of the SIN and Los Alamos Pion Trials.
Schmitt G; von Essen CF; Greiner R; Blattmann H
Radiat Res Suppl; 1985; 8():S272-8. PubMed ID: 3937174
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo studies of the TRIUMF pion therapy beam.
Skarsgard LD; Douglas BG; Denekamp J; Chaplin DJ; Lam GK; Harrison RW; Kornelsen RO; Palcic B
Radiat Res Suppl; 1985; 8():S135-44. PubMed ID: 3937169
[TBL] [Abstract][Full Text] [Related]
12. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
13. Biological effectiveness of fractionated dose of pions in microscopic SCCVII tumors: comparison between tumor control dose and tumor growth time assays.
Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
Jpn J Cancer Res; 1995 Jun; 86(6):600-6. PubMed ID: 7622425
[TBL] [Abstract][Full Text] [Related]
14. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay.
Wouters BG; Lam GK; Oelfke U; Gardey K; Durand RE; Skarsgard LD
Radiat Res; 1996 Aug; 146(2):159-70. PubMed ID: 8693066
[TBL] [Abstract][Full Text] [Related]
15. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
16. The PIOTRON: initial performance, preparation and experience with pion therapy.
von Essen CF; Blattmann H; Crawford JF; Fessenden P; Pedroni E; Perret C; Salzmann M; Shortt K; Walder E
Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1499-509. PubMed ID: 6815138
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
[TBL] [Abstract][Full Text] [Related]
18. Examination of GyE system for HIMAC carbon therapy.
Kanai T; Matsufuji N; Miyamoto T; Mizoe J; Kamada T; Tsuji H; Kato H; Baba M; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):650-6. PubMed ID: 16414376
[TBL] [Abstract][Full Text] [Related]
19. Influence of different dose rates on cell recovery and RBE at different spatial positions during protracted conformal radiotherapy.
Herskind C; Schalla S; Hahn EW; Höver KH; Wenz F
Radiat Prot Dosimetry; 2006; 122(1-4):498-505. PubMed ID: 17223644
[TBL] [Abstract][Full Text] [Related]
20. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy.
Sterzing F; Münter MW; Schäfer M; Haering P; Rhein B; Thilmann C; Debus J
Strahlenther Onkol; 2005 Jan; 181(1):42-8. PubMed ID: 15660192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
